Endocrinology, Vol 114, 1433-1440, Copyright © 1984 by Endocrine Society

ARTICLES

Difference in calcium requirements for forskolin-induced release of prolactin from normal pituitary cells and GH4C1 cells in culture

D Delbeke, JG Scammell and PS Dannies

We investigated the role of Ca++ in cAMP-stimulated PRL release from 1) primary cultures of male rat pituitary glands, 2) primary cultures of estrogen-induced pituitary tumors from Fischer rats, and 3) the pituitary tumor cell line GH4C1. Forskolin, an activator of adenylate cyclase, increased intracellular cAMP concentrations in GH4C1 cells at least 20-fold within 15 min. This increase occurred in the presence or absence of added extracellular Ca++ or in the presence of D600 or Co++. Forskolin increased PRL release from the three types of cells. The three systems differed in the Ca++ sensitivity of forskolin-induced release, but showed little difference in the Ca++ sensitivity of K+- induced release. This was shown in two ways. The cells were incubated either 1) in a medium without added Ca++ or 2) in the presence of a Ca++ channel inhibitor, D600. In normal cells, K+- and forskolin- induced release were equally inhibited when extracellular Ca++ was removed or D600 was added. In GH4C1 cells, Ca++ removal or D600 addition (100 microM) completely blocked K+-induced release, but had little effect on forskolin-induced release. The response of Fischer tumor cells was intermediate between those of normal and GH4C1 cells. 45Ca++ uptake by GH4C1 cells was not affected by forskolin, whereas the release of 45Ca++ from preloaded cells was increased slightly only 30 min after the addition of forskolin in three of four experiments. The difference in Ca++ requirements between normal and GH4C1 cells for forskolin stimulation may be due to the release of cellular Ca++ stores by cAMP. These stores may not be as large in normal cells as they are in GH4C1 cells, and therefore the requirement for extracellular Ca++ occurs. Alternatively, GH4C1 cells may release PRL by a mechanism different from that which normal cells use.

This article has been cited by other articles:

				T. Yonehara, H. Kanasaki, H. Yamamoto, K. Fukunaga, K. Miyazaki, and E. Miyamoto Involvement of Mitogen-Activated Protein Kinase in Cyclic Adenosine 3',5'-Monophosphate-Induced Hormone Gene Expression in Rat Pituitary GH3 Cells Endocrinology, July 1, 2001; 142(7): 2811 - 2819. [Abstract] [Full Text] [PDF]

				S. Suzuki, I. Yamamoto, and J. Arita Mitogen-Activated Protein Kinase-Dependent Stimulation of Proliferation of Rat Lactotrophs in Culture by 3',5'-Cyclic Adenosine Monophosphate Endocrinology, June 1, 1999; 140(6): 2850 - 2858. [Abstract] [Full Text]

				M Waterman, G. Murdoch, R. Evans, and M. Rosenfeld Cyclic AMP regulation of eukaryotic gene transcription by two discrete molecular mechanisms Science, July 19, 1985; 229(4710): 267 - 269. [Abstract] [PDF]